Biogen Inc. (NASDAQ:BIIB), a leading biopharmaceutical company specializing in neurology and rare diseases, finds itself at a critical juncture as it navigates a complex landscape of opportunities and ...

Securities adjusted its outlook on Sage Therapeutics (NASDAQ:SAGE) shares, with analyst Vamil Divan increasing the price target to $9.00 from the previous $6.00, while maintaining a Neutral rating on ...

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Liberty Media Corp. Series C Liberty Formula One-0.89% $29.75B Liberty Media Corp. Series A Liberty Formula One-0.15% $29.75B Liberty Broadband Corp. Cl A-1.36% $11.42B Liberty Broadband Corp. Cl ...

The managers pursue companies with fundamental strengths and long-term prospects that are better than their stock prices indicate. They look for attributes such as accelerating earnings and cash ...

On to its next chapter. Our research team assigns Bronze ratings to strategies they’re confident will outperform a relevant index, or most peers, over a market cycle on a risk-adjusted basis ...

Merck & Co. Inc. 0.85% $248.61B ...

Petroleo Brasileiro S/A Ord-1.00% R$503.67B Petroleo Brasileiro S/A Pref-0.62% R$503.67B ...

Finance of America Cos. Inc.-1.17% $263.75M Finance of America Cos. Inc. Wt 0.00% ...

Companies in which DIIs and FIIs have decreased their holdings QoQ ...

Bonus Dec 03, 2024 Dec 03, 2024 Oct 17, 2024 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Mar 06, 2019 Mar 07, 2019 Jan 18, 2019 Bonus Ratio: 1 share(s) for every 3 shares held Bonus Jun 13, ...

Bonus Jul 13, 2017 Jul 14, 2017 May 29, 2017 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Jul 11, 2013 Jul 13, 2013 May 22, 2013 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Oct 01, ...